Formulation and Evaluation of Fluconazole Microsponge using Eudragit L 100 by Quasi Emulsion Solvent Diffusion Method
The aim of the present study is to formulate and evaluate the fluconazole microsponge by using Eudragit L 100. Microsponge was made because they provide controlled as well as target specific release of the drug. Thus study the effect of stirring rate on the formation of microsponge. Microsponge containing Fluconazole were prepared by quasi-emulsion solvent diffusion method at different stirring rate i.e 500, 800, 1000, 1200 and 1500 rpm. Particle size of prepared microsponge was observed in the range of 76.2 to 32.5μm. Scanning electron microscopy revealed the porous, spherical nature of the microsponges. The production yield, entrapment efficiency and drug content were found to be 78.24%, 82.76%, 81.36%. The impact of Drug: Polymer ratio and process variables i.e stirring speed and stirring time on the physical features of microsponges like production yield, mean particle size, entrapment efficiency were examined. It was shown that production yield, drug content and entrapment efficiency was found to be increase with increase in drug polymer ratio while drug: polymer ratio has reverse effect on particle size, as drug: polymer ratio increase, particle size decrease. As the polymer concentration increased, more amount of polymer surrounding the drug, thus increasing the thickness of the wall of the polymer matrix which lead to extended diffusion path and ultimately to lesser drug release or more sustained release. The effect of stirring rate on the morphology of microsponge. The formulation with higher drug to polymer ratio 1:8 (i.e F4) was chosen to investigate the effect of stirring rate on the morphology of microsponges. The dispersion of the drug and polymer within the aqueous phase was found to be dependent on the agitation speed. As the speed was increased the size of microsponges was reduced and the microsponges were found to be spherical and uniform.
Keywords: Novel drug delivery system, Microsponges, Eudragit L 100, Fluconazole, Quasi-emulsion solvent diffusion method.
(2) Shivani Nanda, Mandeep Kaur, Nikhil Sood, Sahil Nagpal, Microsponge drug delivery system: an overview, World Journal of Pharmacy and Pharmaceutical Sciences, Volume 2, Issue 3, 1032-1043.
(3) D’souza J.I., More H.N (2008). Topical Anti-Inflammatory Gels of Fluocinolone Acetonide Entrapped in Eudragit Based Microsponge Delivery System. Res J Pharm Tech 1(4):502-506.
(4) Aity, S., et al., Microsponges: A novel strategy for drug delivery system. J Adv Pharm technol Res, 2010. 1(3): p. 90-283.
(5) Jain V, Singh R. Development and characterization of eudragit RS 100loaded microsponges and its colonic delivery using natural polysaccharides. Acta Poloniae Pharm Drug Res 2010;67:407-15
(6) Jain V, Singh R. Dicyclomine-loaded eudragit based microsponge with potential for colonic delivery: preparation and characterization. Trop J Pharm Res 2010;9:67-72.
(7) Orlu M, Cevher E, Araman A. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges. Int J Pharm 2006;318:103-17.
(8) Vyas SP, Khar RK (2002). Targeted and controlled drug delivery: novel carrier systems. CBS Publications, 1st ed., New Delhi, 453
(9) Khopade AJ, Jain S, Jain NK (1996). The Microsponge. Eastern Pharmacist :49-53.
(10) N, Sharma PK, Banik K (2011). Recent advances on microsponge delivery system. Int. J. Pharm. Sci. Rev. Res. 8:13-23.
(11) Embil K. and Nacht S.J (1996). The microsponge delivery system (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. J. Microencapsul 13(5):575-588.
(12) D souza JI. The Microsponge Drug Delivery System: For Delivering an Active Ingredient by Controlled Time Release. Pharmaoinfo net. 2008;6:3.
(13) Jelvehgari M., Siahi-Shadbad M.R., Azarmi S., Gary P., Martin A., Nokhodchi A (2006). The microsponge delivery system of benzoyl peroxide: Preparation, characterization and release studies. Int J Pharm 308:124-132.
(14) Demuria D, Forrest A, Rich J. Pharmacokinetic and bioavailability of fluconazole in patients with AIDS. Antimicrob Agents Chemother 37(10), 1993, 2187-92.
(15) Pappas PG, Rex JH, Sobel JD. Guidelines for treatment of candidiasis. Clin Infect Dis 346(4), 2004,161-89.
(16) Baddley JW, Patel M, Bhavnani SM. Association of fluconazole pharmacodynamic with mortality in Patients with candidemia. J Antimicrob Chemother 52(9), 2008, 3022-8.
(17) Sohrab Ershad, Sahar Kangari. Preparation of a fluconazole potentiometric sensor and its application to pharmaceutical analysis and to drug recovery from biological fluids. Int J Electrochem Sci 4(2), 2009, 1100-1108.
(18) Marciniec B, Dettlaff K, Joroszkiewicz E, Bafeltowska J. Radiochemical stability of fluconazole in the solid state. J Pharm Biomed Anal 43(5), 2007, 1879-1880.
(19) Koks CHW, Meen horst PL, Hillebrand MJX, Bult A, Beijnen. Pharmacokinetic of fluconazole in saliva and plasma after administration of an oral suspension and capsules. J Antimicrobiol Chemother 9(5), 1996, 19351937.
(20) Sarat Chandra Prasad, Ajay. M, Nagendra Babu. B, Prathyusha.P, Audinarayana.N Microsponge Drug Delivery System: A Review. Int J Pharm Research. 2011; 4: 5.
(21) Nacht S, Kantz M. The Microsponge: A novel topical programmable delivery system. Top Drug DelivSyst.1992; 42:299-325.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).